Sino Biopharmaceutical's total assets for Q2 2022 were ¥64.93B, an increase of 7.25% from the previous quarter. SBMFF total liabilities were ¥― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.